EA4 – 10 mg

Brand:
Cayman
CAS:
389614-94-2
Storage:
-20
UN-No:
Non-Hazardous - /

rPLA2 is a calcium-dependent cytosolic phospholipase A2 (cPLA2) initially isolated and characterized from bovine and human red blood cells (RBCs).{10767} It has a molecular mass of 42 kDa and biochemical properties similar to cPLA2 Type IV. EA4 is a quinone derivative that inhibits rPLA2 with a Ki of 130 µM. It inhibits the ionophore-induced arachidonic acid release from human and bovine red blood cells (RBCs), indicating that rPLA2 is responsible for the Ca2+-dependent release of arachidonic acid from mammalian RBCs.{10767} EA4 causes significant time- and concentration-dependent induction of cytochrome P450 1A1 (CYP1A1) mRNA and protein in murine hepatoma Hepa-1c1c7 cells.{13350} EA4 also modulates CYP1A1 and CYP1B1 expression in other cell lines such as MCF-7, Hep-G2, and HL-60.{13350}  

 

Available on backorder

SKU: 10111 - 10 mg Category:

Description

A quinone derivative that inhibits red blood cell PLA2 with a Ki value of 130 µM


Formal name: 7-chloro-6-[4-(diethylamino)phenyl]-5,8-quinolinedione

Synonyms: 

Molecular weight: 340.8

CAS: 389614-94-2

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Phospholipases||Research Area|Lipid Biochemistry|Glycerophospholipids|Phospholipases||Research Area|Toxicology|Drug Metabolism|Cytochrome P450